COVID: Clinical Trials

4 trials for COVID, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

4 completed. 4 Phase 4.

By phase and status

PhaseTrialsStatus
Phase 44Completed 4

Follow COVID: new trials by email Literature Review of COVID trials Research Report on COVID

Trials (filtered) newest first · largest first

All 4 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Cholecalciferol to Improve the Outcomes of COVID-19 Patients
Vitamin D, Placebo - COVID
Phase 4CompletedVitamin D Study Group2182020-08-112021-07-30
OPV as Potential Protection Against COVID-19
oral polio vaccine + information, Information - Poliovirus Vaccine, Oral, COVID
Phase 4CompletedBandim Health Project37292020-07-152026-04-07
Sofosbuvir/Ledipasvir and Nitazoxanide for Treatment of COVID-19
Sofosbuvir and Ledipasvir, Nitazoxanide - COVID
Phase 4CompletedAssiut University2402020-07-152020-11-12
Weight-Adjusted vs Fixed Low Doses of Low Molecular Weight Heparin For Venous Thromboembolism Prevention in COVID-19
Enoxaparin - COVID, Thrombosis
Phase 4CompletedCentral Hospital, Nancy, France10002020-05-132023-08-07

Narrower conditions

Coronavirus Infections (1)  ·  Pulmonary Embolism (1)  ·  Respiratory Insufficiency (1)  ·  Thrombosis (1)  ·  Venous Thromboembolism (1)  ·  Venous Thrombosis (1)

Broader conditions

Respiratory Tract Diseases (2)  ·  Cardiovascular Diseases (1)  ·  Coronaviridae Infections (1)  ·  Embolism (1)  ·  Embolism and Thrombosis (1)  ·  Infections (1)  ·  Lung Diseases (1)  ·  Nidovirales Infections (1)  ·  RNA Virus Infections (1)  ·  Respiration Disorders (1)  ·  Thromboembolism (1)  ·  Vascular Diseases (1)  ·  Virus Diseases (1)

Interventions

Cholecalciferol (1)  ·  Dalteparin (1)  ·  Enoxaparin (1)  ·  Nadroparin (1)  ·  Poliovirus Vaccine, Oral (1)  ·  Therapeutics (1)  ·  Tinzaparin (1)  ·  Vitamin D (1)  ·  ledipasvir, sofosbuvir drug combination (1)  ·  nitazoxanide (1)

Sponsors

Assiut University (1)  ·  Bandim Health Project (1)  ·  Central Hospital, Nancy, France (1)  ·  Vitamin D Study Group (1)

Countries

Argentina (1)  ·  Egypt (1)  ·  France (1)  ·  Guinea-Bissau (1)

Top investigators

Ane Fisker, MD, PhD (1)  ·  Carlos Tajer, MD (1)  ·  El Mehdi Siaghy (1)  ·  Felipe Inserra, MD (1)  ·  Haidi K Ramadan, PhD (1)  ·  Javier Mariani, MD (1)  ·  Laura Antonietti, MD (1)  ·  Mohamed El Kassas, PhD (1)  ·  Mohammed A Medhat, PhD (1)  ·  Walter Manucha, PhD (1)

Results publications

PMID 32422305, PMID 33502773, PMID 33522946, PMID 35244208, PMID 35622854, PMID 36193229, PMID 37350990